Atlas Trials

All-Trans Retinoic Acid in Combination With Standard Induction and Consolidation Therapy in Older Patients With Newly Diagnosed Acute Myeloid Leukemia

Clinical trial NCT00151255 · COMPLETED

Trial details

NCT number
NCT00151255
Sponsor
University of Ulm
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Acute Myeloid Leukemia
Start date
2004-06-01
Primary completion
2009-06-01
Enrollment
500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.